Show simple item record

dc.contributor.authorDe Franco, Elisaen
dc.contributor.authorEllard, Sianen
dc.identifier.citationGenome, Exome, and Targeted Next-Generation Sequencing in Neonatal Diabetes. 2015, 62 (4):1037-53 Pediatr. Clin. North Am.en
dc.description.abstractThe use of targeted gene panels now allows the analysis of all the genes known to cause a disease in a single test. For neonatal diabetes, this has resulted in a paradigm shift with patients receiving a genetic diagnosis early and the genetic results guiding their clinical management. Exome and genome sequencing are powerful tools to identify novel genetic causes of known diseases. For neonatal diabetes, the use of these technologies has resulted in the identification of 2 novel disease genes (GATA6 and STAT3) and a novel regulatory element of PTF1A, in which mutations cause pancreatic agenesis.en
dc.rightsArchived with thanks to Pediatric clinics of North Americaen
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.::Geneticsen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.titleGenome, Exome, and Targeted Next-Generation Sequencing in Neonatal Diabetes.en
dc.typeJournal Articleen
dc.identifier.journalPediatric Clinics of North Americaen

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record